NG25 trihydrochloride is a dual TAK1 and MAP4K2 inhibitor ( IC 50 : 149 nM and 21.7 nM respectively). NG25 sensitizes the breast cancer cells to Doxorubicin ( HY-15142A ), and enhances apoptosis . NG25 trihydrochloride can be used for research of various cancers.
Products | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > MAP3K | Products > Signaling Pathways > MAP4K
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.